Hoth Therapeutics Inc
NASDAQ:HOTH
Balance Sheet
Balance Sheet Decomposition
Hoth Therapeutics Inc
Hoth Therapeutics Inc
Balance Sheet
Hoth Therapeutics Inc
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
0
|
2
|
3
|
9
|
6
|
9
|
7
|
|
| Cash |
1
|
0
|
2
|
3
|
9
|
6
|
9
|
7
|
|
| Short-Term Investments |
0
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
1
|
1
|
3
|
5
|
11
|
7
|
9
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
-59%
|
3
+468%
|
5
+85%
|
11
+110%
|
7
-38%
|
10
+41%
|
8
-19%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+600%
|
0
+26%
|
1
+36%
|
1
+83%
|
2
+49%
|
1
-57%
|
1
+18%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
2
|
5
|
12
|
19
|
34
|
45
|
53
|
60
|
|
| Additional Paid In Capital |
3
|
5
|
15
|
24
|
44
|
50
|
62
|
67
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
-87%
|
2
+1 500%
|
5
+94%
|
10
+112%
|
5
-48%
|
9
+72%
|
7
-22%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-59%
|
3
+468%
|
5
+85%
|
11
+110%
|
7
-38%
|
10
+41%
|
8
-19%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
1
|
1
|
1
|
4
|
8
|
|